| Description | BC-05, an orally active inhibitor targeting CD13 and the proteasome, displays potent inhibition with IC50 values of 0.13 μM against human CD13 and 1.39 μM for the 20S proteasome. It is utilized in the research of multiple myeloma [1]. |
| molecular weight | 464.27 |
| Molecular formula | C21H29BN2O9 |
| CAS | 2260717-73-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |